X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (113) 113
oncology (97) 97
index medicus (86) 86
female (72) 72
male (60) 60
middle aged (53) 53
aged (49) 49
adult (48) 48
cancer (35) 35
animals (33) 33
surgery (32) 32
article (29) 29
colorectal cancer (29) 29
aged, 80 and over (28) 28
celecoxib (28) 28
colorectal-cancer (26) 26
mice (25) 25
tumors (25) 25
neoplasm staging (24) 24
mutation (21) 21
mice, inbred c57bl (20) 20
prognosis (20) 20
abridged index medicus (19) 19
disease-free survival (19) 19
risk (19) 19
colonic neoplasms - pathology (18) 18
expression (18) 18
microsatellite instability (18) 18
care and treatment (17) 17
colonic neoplasms - genetics (17) 17
colorectal neoplasms - genetics (17) 17
risk factors (17) 17
survival (17) 17
treatment outcome (17) 17
antineoplastic agents - therapeutic use (15) 15
chemotherapy (15) 15
colon cancer (15) 15
colorectal neoplasms - prevention & control (15) 15
familial adenomatous polyposis (14) 14
prevention (14) 14
research (14) 14
chemotherapy, adjuvant (13) 13
colonic neoplasms - drug therapy (13) 13
therapy (13) 13
carcinoma (12) 12
clinical trials (12) 12
colon-cancer (12) 12
colorectal neoplasms - pathology (12) 12
immunohistochemistry (12) 12
proportional hazards models (12) 12
pyrazoles - therapeutic use (12) 12
sarcoma (12) 12
sulfonamides - therapeutic use (12) 12
adenoma - prevention & control (11) 11
follow-up studies (11) 11
kaplan-meier estimate (11) 11
medicine & public health (11) 11
risk assessment (11) 11
young adult (11) 11
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
beta-catenin (10) 10
colon (10) 10
cyclooxygenase 2 inhibitors - adverse effects (10) 10
fluorouracil (10) 10
analysis (9) 9
colonic neoplasms - mortality (9) 9
colorectal adenomas (9) 9
dna methylation (9) 9
gastroenterology and hepatology (9) 9
imatinib mesylate (9) 9
medicine, general & internal (9) 9
phenotype (9) 9
pyrazoles - adverse effects (9) 9
retrospective studies (9) 9
sulfonamides - adverse effects (9) 9
adjuvant chemotherapy (8) 8
adjuvant therapy (8) 8
antineoplastic agents - pharmacology (8) 8
aspirin (8) 8
cyclooxygenase 2 inhibitors - therapeutic use (8) 8
dna mismatch repair (8) 8
gastroenterology & hepatology (8) 8
genetic aspects (8) 8
nonsteroidal antiinflammatory drugs (8) 8
recurrence (8) 8
survival rate (8) 8
time factors (8) 8
trial (8) 8
adenoma (7) 7
anti-inflammatory agents, non-steroidal - pharmacology (7) 7
apoptosis (7) 7
beta catenin (7) 7
breast-cancer (7) 7
camptothecin - analogs & derivatives (7) 7
chemoprevention (7) 7
clinical trials as topic (7) 7
colonic neoplasms - surgery (7) 7
cytoskeletal proteins - metabolism (7) 7
genetic predisposition to disease (7) 7
genotype (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 12/2009, Volume 361, Issue 25, pp. 2449 - 2460
This review gives an account of recent advances in our knowledge of the molecular mechanisms in colorectal cancer. Genetic changes in the germ line, combined... 
Journal Article
The Oncologist, ISSN 1083-7159, 07/2018, Volume 23, Issue 7, pp. 868 - 869
Reflections on the legacies of Drs. James and Jimmie Holland, who became the most impactful couple in oncology as one worked to save lives by developing new... 
ONCOLOGY | In Memoriam
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 09/2019, Volume 37, Issue 26, pp. 2301 - 2301
Journal Article
The Oncologist, ISSN 1083-7159, 08/2017, Volume 22, Issue 8, pp. 1012 - 1013
The oncology community remembers, with great affection, Dr. Robert L. Comis, and his many contributions to the field. 
ONCOLOGY | In Memoriam
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. e21544 - e21544
Journal Article
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 07/2019, p. JCO1901584
Journal Article
Cancer Research, ISSN 0008-5472, 10/2014, Volume 74, Issue 19 Supplement, pp. 3794 - 3794
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2017, Volume 35, Issue 4_suppl, pp. 524 - 524
524 Background: The APC trial showed that patients at high risk for colorectal adenoma development experienced a 33-45% reduction in post-polypectomy adenoma... 
Journal Article
Journal of the American College of Surgeons, ISSN 1072-7515, 2014, Volume 219, Issue 3, pp. S129 - S130
Journal Article
Gastroenterology, ISSN 0016-5085, 2014, Volume 146, Issue 5, pp. S-1074 - S-1074
Journal Article
JAMA, ISSN 0098-7484, 06/2017, Volume 317, Issue 23, pp. 2392 - 2401
IMPORTANCE: Combining biologic monoclonal antibodies with chemotherapeutic cytotoxic drugs provides clinical benefit to patients with advanced or metastatic... 
MEDICINE, GENERAL & INTERNAL | LEUCOVORIN | FIRE-3 | THERAPY | FOLFIRI PLUS CETUXIMAB | PHASE-II | IRINOTECAN | OXALIPLATIN | FLUOROURACIL | TUMORS | PROGRESSION | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Bevacizumab - therapeutic use | United States | Bevacizumab - adverse effects | Colorectal Neoplasms - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents - therapeutic use | Cetuximab - therapeutic use | Cetuximab - adverse effects | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Antineoplastic Agents - adverse effects | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Adult | Camptothecin - administration & dosage | Female | Angiogenesis Inhibitors - adverse effects | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Camptothecin - adverse effects | Kaplan-Meier Estimate | Treatment Outcome | Canada | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Colorectal Neoplasms - secondary | Aged | Genes, ras | Organoplatinum Compounds - adverse effects | Chemotherapy | Usage | Care and treatment | Research | Colorectal cancer | Cancer | Drugs | Medical research | Colorectal carcinoma | Clinical trials | Cytotoxicity | Patients | Survival | K-Ras protein | Bevacizumab | Metastases | Survival analysis | Irinotecan | Randomization | Oxaliplatin | Monoclonal antibodies | Tumors
Journal Article
The Oncologist, ISSN 1083-7159, 11/2014, Volume 19, Issue 11, pp. 1179 - 1185
Since their inception in the 1950s, the National Cancer Institute‐funded cancer cooperative groups have been important contributors to cancer clinical and... 
Clinical trials | National Cancer Institute | Institute of Medicine | Drug development
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 04/2010, Volume 362, Issue 13, pp. 1246 - 1247
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2007, Volume 8, Issue 5, pp. 439 - 443
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.